You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Colorcon
Medtronic
Boehringer Ingelheim
McKesson

Last Updated: March 30, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SONIDEGIB PHOSPHATE

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for sonidegib phosphate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02303041 Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma Active, not recruiting National Cancer Institute (NCI) N/A 2015-02-01 This pilot trial studies how well sonidegib and buparlisib work in treating patients with basal cell carcinoma that has spread to other places in the body. Sonidegib and buparlisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
NCT02303041 Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma Active, not recruiting Anne Chang N/A 2015-02-01 This pilot trial studies how well sonidegib and buparlisib work in treating patients with basal cell carcinoma that has spread to other places in the body. Sonidegib and buparlisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
NCT03897036 Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC) Not yet recruiting Senhwa Biosciences, Inc. Phase 1 2019-03-01 This study is to determine the recommended phase II dose (RP2D) and schedule of CX-4945 when administered orally twice daily for 28 consecutive days, in a 4-week (28 days) cycle, in patients with locally advanced or metastatic basal cell carcinoma (BCC). The safety and tolerability of CX-4945, preliminary evidence of antitumor effect, and the effect of CX-4945 treatment on the Hh signaling pathway will also be evaluated in this study.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for sonidegib phosphate

Condition Name

Condition Name for sonidegib phosphate
Intervention Trials
Carcinoma, Basal Cell 1
Basal Cell Carcinoma of the Skin 1
Recurrent Skin Cancer 1
Nevoid Basal Cell Carcinoma Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for sonidegib phosphate
Intervention Trials
Carcinoma, Basal Cell 2
Carcinoma 2
Skin Neoplasms 1
Basal Cell Nevus Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for sonidegib phosphate

Trials by Country

Trials by Country for sonidegib phosphate
Location Trials
United States 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for sonidegib phosphate
Location Trials
California 2
Texas 1
Florida 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for sonidegib phosphate

Clinical Trial Phase

Clinical Trial Phase for sonidegib phosphate
Clinical Trial Phase Trials
Phase 1 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for sonidegib phosphate
Clinical Trial Phase Trials
Active, not recruiting 1
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for sonidegib phosphate

Sponsor Name

Sponsor Name for sonidegib phosphate
Sponsor Trials
Senhwa Biosciences, Inc. 1
Anne Chang 1
National Cancer Institute (NCI) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for sonidegib phosphate
Sponsor Trials
Other 1
NIH 1
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Express Scripts
Medtronic
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.